Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
CHS downplays impact of ACA subsidies' likely expiration
President and Interim CEO Kevin Hammons on Tuesday made a point to emphasize his company's limited exposure to ACA enrollment upheaval.
Dave Muoio
Nov 11, 2025 1:00pm
Sponsored
Turning post-acute visibility into TEAM success with actionable insights
Nov 10, 2025 8:00am
Report: Payers need to do more to prove value to plan sponsors
Nov 11, 2025 12:20pm
Sponsored
Baxter’s Room Temperature HEMOPATCH Sealing Hemostat Gains Momentum in Australia and New Zealand
Nov 10, 2025 8:00am
Government shutdown updates: Senate passes bill to reopen gov
Nov 11, 2025 10:00am
Kaiser Permanente logs 0.7% operating margin for Q3 2025
Nov 10, 2025 4:55pm
More News
Fierce Healthcare Layoff Tracker—Tower Health laying off 350
Nov 10, 2025 12:00pm
Will the Trump admin intervene on healthcare consolidation?
Nov 10, 2025 11:33am
Dems make push to roll back CMS' AI-powered prior auth model
Nov 10, 2025 11:29am
UnitedHealthcare slashes RPM coverage for most conditions
Nov 7, 2025 9:00pm